|
Gastroenterology
|
|
|
The Food and Drug Administration today released a drug safety communication about proton pump inhibitors (PPIs) through its MedWatch Safety Information and Adverse Reporting Program, telling the public that Clostridium difficile–associated diarrhea can be associated with use of PPIs. The PPI... »
SAN FRANCISCO – The benefit of bevacizumab in some patients with advanced gastric cancer appears to vary by disease subtype, based on an exploratory analysis of data from the phase III AVAGAST trial. The global trial randomized 774 patients to chemotherapy plus placebo or bevacizumab (Avastin), an... »
The Food and Drug Administration has identified a new risk factor for progressive multifocal leukoencephalopathy, a life-threatening brain infection associated with the use of natalizumab, an immunomodulatory agent used to treat multiple sclerosis and Crohn’s disease. Testing positive for... »
Interested in being notified of new Gastroenterology news?
Click here to view our Gastroenterology RSS Feed.
| Feb 5 - 12 Departs Ft. Lauderdale, FL | Preventive Medicine |
| Feb 6 - 11 Dallas, TX | Society for Maternal-Fetal Medicine (SMFM): Annual Meeting (The Pregnancy Meeting) |
| Feb 6 - 10 Sarasota, FL | Rheumatology: Improving Primary Care Outcomes Through Diagnosis and Treatment |
| Feb 7 - 11 San Francisco, CA | American Academy of Orthopaedic Surgeons (AAOS): Annual Meeting |
| Feb 8 - 12 Naples, FL | Dermatology Foundation (DF): Clinical Symposia |
| Feb 8 - 11 Barcelona, | International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) |
| Feb 8 - 10 San Diego, CA | American Academy of Emergency Medicine (AAEM): Annual Scientific Assembly |
| Feb 9 - 11 New York, NY | Integrative Healthcare Symposium |
| Feb 9 - 11 New Orleans, LA | American Federation for Medical Research (AFMR): Southern Regional Meeting |
| Feb 12 - 15 Freiburg, | German Society for Thoracic and Cardiovascular Surgery: 41st Annual Meeting |